|
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial
|
March 13, 2024
|
PC3I Authors Catherine Lai |
Cancers
|
|
Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective
|
March 12, 2024
|
PC3I Authors Ronac Mamtani |
Journal of Medical Economics
|
|
US Medicare Hospice and Palliative Medicine Physician Workforce and Service Delivery in 2008-2020
|
March 11, 2024
|
PC3I Authors |
Journal of Pain and Symptom Management
|
|
Surgical Management of Metastatic Adrenocortical Carcinoma
|
March 11, 2024
|
PC3I Authors Sara Ginzberg |
World Journal of Surgery
|
|
Delays in cervical cancer treatment initiation for patients living with or without HIV in Botswana: An observational cohort analysis (2015-2019)
|
March 10, 2024
|
PC3I Authors Surbhi Grover; Katharine Rendle |
International Journal of Radiation Oncology, Biology, Physics
|
|
Understanding Health-Related Social Risks
|
March 10, 2024
|
PC3I Authors Farouk Dako |
Journal of the American College of Radiology
|
|
Radiologists’ Role in Decolonizing Global Health
|
March 10, 2024
|
PC3I Authors Farouk Dako |
Journal of the American College of Radiology
|
|
Drivers of Global Healthcare Worker Migration
|
March 10, 2024
|
PC3I Authors Farouk Dako |
Journal of the American College of Radiology
|
|
Prior Authorization and Association With Delayed or Discontinued Prescription Fills
|
March 10, 2024
|
PC3I Authors Michael Anne Kyle |
Journal of Clinical Oncology
|
|
Should I See You Again Soon? A Multispecialty Assessment of the Impact and Burden of Preoperative History and Physical Update Visits
|
March 8, 2024
|
PC3I Authors Sara Ginzberg |
Journal of the American College of Surgeons
|
|
The unique risk factor profile of triple negative breast cancer: a comprehensive meta-analysis
|
March 6, 2024
|
PC3I Authors Anne Marie McCarthy; Oluwadamilola "Lola" Fayanju |
Journal of the National Cancer Institute
|
|
The Patient Symptom Experience After Tisagenlecleucel and Lisocabtagene Maraleucel CAR T-Cell Therapy for Lymphoma
|
March 5, 2024
|
PC3I Authors |
Seminars in Oncology Nursing
|
|
Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels
|
March 3, 2024
|
PC3I Authors Charu Aggarwal |
Lung Cancer (Amsterdam, Netherlands)
|
|
Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?
|
March 1, 2024
|
PC3I Authors Roger Kim |
Cancer Biomarkers
|
|
Racial and Ethnic Disparities in Breast Cancer: A Collaboration Between the American College of Radiology Commissions on Women and Diversity and Breast Imaging
|
March 1, 2024
|
PC3I Authors Oluwadamilola "Lola" Fayanju |
Journal of Breast Imaging
|
|
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy
|
February 28, 2024
|
PC3I Authors Ronac Mamtani |
European Urology
|
|
Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship
|
February 27, 2024
|
PC3I Authors Alix Seif |
Pediatric Blood & Cancer
|
|
The global burden of cervical cancer requiring surgery: database estimates
|
February 26, 2024
|
PC3I Authors Surbhi Grover |
Infectious Agents and Cancer
|
|
Artificial intelligence and technology collaboratories: Empowering innovation in AI + AgeTech
|
February 26, 2024
|
PC3I Authors George Demiris |
Journal of the American Geriatrics Society
|
|
Five-Year Outcomes of a Phase 1/2 Trial of Accelerated Partial Breast Irradiation Using Proton Therapy for Women With Stage 0-IIA Breast Cancer
|
February 26, 2024
|
PC3I Authors Oluwadamilola "Lola" Fayanju |
Advances in Radiation Oncology
|
